Veyrah Law Advises Pristyn Care on Raising USD 12 Million from Multiple Investors

Pristyn Care, a health delivery start-up, has raised USD 12 Million in Pre-Series C funding from Sequoia Capital (along with its affiliate), Hummingbird Ventures (along with its affiliate), and Epiq Capital

Veyrah Law advised Pristyn Care, led by partner Ajay Joseph; principal associate Arun Mohanty; associates Anshul Pandey and Priyanka Zaveri. The Veyrah Law team assisted Pristyn Care with structuring, drafting/negotiating the term sheet, drafting/negotiating and signing the transaction documents and closing.

Cyril Amarchand Mangaldas advised Sequoia Capital and its affiliate, led by head of corporate, Reeba Chacko and partner, Chandan Kota; principal associate Preseedha Premnath.

IndusLaw advised Hummingbird Ventures and its affiliate led by partner Siddharth Manchanda; counsel Minhaz Lokhandwala; associate Rohit Jain.

Veritas Legal advised Epiq Capital, led by partner Tushar Raut; associate Anish Patel.

Pristyn Care was founded in late 2018 and offers patients affordable advanced surgical care through innovative surgical techniques and recovery measures. It offers patients a range of elective surgeries across proctology, gynaecology, urology, ENT, laparoscopy, vascular, ophthal, aesthetics and orthopedics.

The deal was completed on September 25, 2020 and announced on September 28, 2020.

 

The rules of the Bar Council of India prohibit lawyers and law firms from advertising or soliciting for work. This website is not meant for advertising the practice or for soliciting clients and is solely created for providing information. Any action taken by you based on the information provided in this website is at your own risk and Veyrah Law or its members will not be liable for any loss you suffer due to such actions. By accepting the terms contained here you agree that you have read and understood these terms, ‘Terms of Use’ and the ‘Privacy Policy’ contained in this website. Further, you agree that you are viewing the contents of this website at your own discretion to obtain necessary information.